Annual EBITDA:
$607.80M+$81.20M(+15.42%)Summary
- As of today, SGRY annual EBITDA is $607.80 million, with the most recent change of +$81.20 million (+15.42%) on December 31, 2024.
- During the last 3 years, SGRY annual EBITDA has risen by +$181.30 million (+42.51%).
- SGRY annual EBITDA is now at all-time high.
Performance
SGRY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$159.50M+$33.60M(+26.69%)Summary
- As of today, SGRY quarterly EBITDA is $159.50 million, with the most recent change of +$33.60 million (+26.69%) on June 30, 2025.
- Over the past year, SGRY quarterly EBITDA has increased by +$20.60 million (+14.83%).
- SGRY quarterly EBITDA is now -19.28% below its all-time high of $197.60 million, reached on December 31, 2024.
Performance
SGRY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$631.30M+$20.60M(+3.37%)Summary
- As of today, SGRY TTM EBITDA is $631.30 million, with the most recent change of +$20.60 million (+3.37%) on June 30, 2025.
- Over the past year, SGRY TTM EBITDA has increased by +$68.60 million (+12.19%).
- SGRY TTM EBITDA is now at all-time high.
Performance
SGRY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SGRY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +15.4% | +14.8% | +12.2% |
| 3Y3 Years | +42.5% | +36.3% | +38.2% |
| 5Y5 Years | +62.0% | +290.9% | +99.0% |
SGRY EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +42.5% | -19.3% | +43.7% | at high | +33.6% |
| 5Y | 5-Year | at high | +88.7% | -19.3% | +84.4% | at high | +99.0% |
| All-Time | All-Time | at high | +738.0% | -19.3% | +727.7% | at high | +3176.1% |
SGRY EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $159.50M(+26.7%) | $631.30M(+3.4%) |
| Mar 2025 | - | $125.90M(-36.3%) | $610.70M(+0.6%) |
| Dec 2024 | $607.80M(+15.4%) | $197.60M(+33.2%) | $606.90M(+4.3%) |
| Sep 2024 | - | $148.30M(+6.8%) | $582.00M(+3.4%) |
| Jun 2024 | - | $138.90M(+13.8%) | $562.70M(+1.3%) |
| Mar 2024 | - | $122.10M(-29.3%) | $555.60M(+2.0%) |
| Dec 2023 | $526.60M(+3.8%) | $172.70M(+33.9%) | $544.50M(+1.7%) |
| Sep 2023 | - | $129.00M(-2.1%) | $535.40M(+1.1%) |
| Jun 2023 | - | $131.80M(+18.7%) | $529.40M(+2.9%) |
| Mar 2023 | - | $111.00M(-32.2%) | $514.60M(+1.4%) |
| Dec 2022 | $507.50M(+19.0%) | $163.60M(+33.0%) | $507.50M(+7.4%) |
| Sep 2022 | - | $123.00M(+5.1%) | $472.60M(+3.4%) |
| Jun 2022 | - | $117.00M(+12.6%) | $456.90M(+2.9%) |
| Mar 2022 | - | $103.90M(-19.3%) | $443.90M(+4.1%) |
| Dec 2021 | $426.50M(+32.4%) | $128.70M(+19.9%) | $426.50M(+1.7%) |
| Sep 2021 | - | $107.30M(+3.2%) | $419.40M(+2.2%) |
| Jun 2021 | - | $104.00M(+20.2%) | $410.40M(+18.2%) |
| Mar 2021 | - | $86.50M(-28.9%) | $347.20M(+7.8%) |
| Dec 2020 | $322.10M(-14.2%) | $121.60M(+23.7%) | $322.10M(+1.5%) |
| Sep 2020 | - | $98.30M(+140.9%) | $317.20M(+3.3%) |
| Jun 2020 | - | $40.80M(-33.6%) | $307.10M(-14.1%) |
| Mar 2020 | - | $61.40M(-47.4%) | $357.50M(-4.7%) |
| Dec 2019 | $375.20M | $116.70M(+32.3%) | $375.20M(+2.5%) |
| Sep 2019 | - | $88.20M(-3.3%) | $366.10M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $91.20M(+15.3%) | $357.01M(+6.0%) |
| Mar 2019 | - | $79.10M(-26.5%) | $336.71M(+5.9%) |
| Dec 2018 | $317.97M(+38.4%) | $107.60M(+36.0%) | $317.91M(+4.8%) |
| Sep 2018 | - | $79.11M(+11.6%) | $303.21M(+18.1%) |
| Jun 2018 | - | $70.89M(+17.6%) | $256.65M(+9.2%) |
| Mar 2018 | - | $60.30M(-35.1%) | $235.03M(+2.3%) |
| Dec 2017 | $229.72M(-6.2%) | $92.90M(+185.4%) | $229.78M(+12.4%) |
| Sep 2017 | - | $32.55M(-33.9%) | $204.34M(-11.6%) |
| Jun 2017 | - | $49.27M(-10.5%) | $231.11M(-5.9%) |
| Mar 2017 | - | $55.05M(-18.4%) | $245.63M(+0.3%) |
| Dec 2016 | $244.88M(+16.1%) | $67.46M(+13.7%) | $244.88M(+6.9%) |
| Sep 2016 | - | $59.32M(-7.0%) | $228.98M(+2.5%) |
| Jun 2016 | - | $63.79M(+17.5%) | $223.37M(+4.4%) |
| Mar 2016 | - | $54.30M(+5.3%) | $213.94M(+1.4%) |
| Dec 2015 | $211.00M(+95.1%) | $51.57M(-4.0%) | $210.97M(+4.4%) |
| Sep 2015 | - | $53.70M(-1.2%) | $201.99M(+18.1%) |
| Jun 2015 | - | $54.37M(+5.9%) | $171.09M(+22.0%) |
| Mar 2015 | - | $51.33M(+20.5%) | $140.21M(+29.6%) |
| Dec 2014 | $108.15M(+31.0%) | $42.59M(+86.8%) | $108.15M(+65.0%) |
| Sep 2014 | - | $22.80M(-2.9%) | $65.56M(+53.3%) |
| Jun 2014 | - | $23.48M(+21.9%) | $42.75M(+121.9%) |
| Mar 2014 | - | $19.27M | $19.27M |
| Dec 2013 | $82.53M(+13.8%) | - | - |
| Dec 2012 | $72.53M | - | - |
FAQ
- What is Surgery Partners, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Surgery Partners, Inc.?
- What is Surgery Partners, Inc. annual EBITDA year-on-year change?
- What is Surgery Partners, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Surgery Partners, Inc.?
- What is Surgery Partners, Inc. quarterly EBITDA year-on-year change?
- What is Surgery Partners, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Surgery Partners, Inc.?
- What is Surgery Partners, Inc. TTM EBITDA year-on-year change?
What is Surgery Partners, Inc. annual EBITDA?
The current annual EBITDA of SGRY is $607.80M
What is the all-time high annual EBITDA for Surgery Partners, Inc.?
Surgery Partners, Inc. all-time high annual EBITDA is $607.80M
What is Surgery Partners, Inc. annual EBITDA year-on-year change?
Over the past year, SGRY annual EBITDA has changed by +$81.20M (+15.42%)
What is Surgery Partners, Inc. quarterly EBITDA?
The current quarterly EBITDA of SGRY is $159.50M
What is the all-time high quarterly EBITDA for Surgery Partners, Inc.?
Surgery Partners, Inc. all-time high quarterly EBITDA is $197.60M
What is Surgery Partners, Inc. quarterly EBITDA year-on-year change?
Over the past year, SGRY quarterly EBITDA has changed by +$20.60M (+14.83%)
What is Surgery Partners, Inc. TTM EBITDA?
The current TTM EBITDA of SGRY is $631.30M
What is the all-time high TTM EBITDA for Surgery Partners, Inc.?
Surgery Partners, Inc. all-time high TTM EBITDA is $631.30M
What is Surgery Partners, Inc. TTM EBITDA year-on-year change?
Over the past year, SGRY TTM EBITDA has changed by +$68.60M (+12.19%)